Dermatology Handbook

The professional's guide to product selection



Meda Pharmaceuticals


Aldara contains imiquimod, an immune response modifier. It is effective against viral infections and acts as an anti-tumour agent, principally by induction of alpha interferon and other cytokines


For the topical treatment of small superficial basal cell carcinomas (sBCCs) in adults and clinically typical, non-hyperkeratotic, non-hypertrophic actinic keratoses (AKs) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy, and other topical treatment options are contraindicated or less appropriate. It is also indicated for the treatment of external genital and perianal warts (condylomata acuminata) in adults

Preparations Available


Sizes Available

12-sachet pack



More on: Topical treatments , Skin cancer (and actinic keratoses) treatments